{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:50:03Z","timestamp":1780534203344,"version":"3.54.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1999,7,1]],"date-time":"1999-07-01T00:00:00Z","timestamp":930787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1999,7,1]],"date-time":"1999-07-01T00:00:00Z","timestamp":930787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"published-print":{"date-parts":[[1999,7]]},"DOI":"10.1023\/a:1009813312936","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T23:53:29Z","timestamp":1040601209000},"page":"139-143","source":"Crossref","is-referenced-by-count":31,"title":["Preliminary Observations on the Use of Midodrine Hydrochloride in the Treatment of Refractory Neurocardiogenic Syncope"],"prefix":"10.1007","volume":"3","author":[{"given":"Blair P.","family":"Grubb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Karas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Kosinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Boehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"211831_CR1","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00001573-199601000-00006","volume":"11","author":"BP Grubb","year":"1996","unstructured":"Grubb BP, Kosinski D. Current trends in etiology, diagnosis and management of neurocardiogenic syncope. Curr Opin Cardiol 1996;11:32\u201341.","journal-title":"Curr Opin Cardiol"},{"key":"211831_CR2","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2165\/00003495-198938050-00004","volume":"38","author":"D McTavish","year":"1989","unstructured":"McTavish D, Goa KL. Midodrine: A review of its pharmacologic properties and therapeutic use in orthostatic hypotension and secondary hypotensive disorders. Drugs 1989;38:757\u2013777.","journal-title":"Drugs"},{"key":"211831_CR3","first-page":"125","volume":"12","author":"JL. Gilden","year":"1993","unstructured":"Gilden JL. Midodrine in neurogenic orthostatic hypotension. Int Angiol 1993;12:125\u2013131.","journal-title":"Int Angiol"},{"key":"211831_CR4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0002-9343(93)90230-M","volume":"95","author":"J Jankovic","year":"1993","unstructured":"Jankovic J, Gilden JL. Hiner BL, et al. Neurogenic orthostatic hypotension: A double-blind placebo-controlled study with midodrine. Am J Med 1993;95:38\u201347.","journal-title":"Am J Med"},{"key":"211831_CR5","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1001\/jama.1997.03540370036033","volume":"13","author":"P Low","year":"1997","unstructured":"Low P, Gilden JL, Freeman R, et al. Efficacy of midodrine vs. placebo in neurogenic orthostatic hypotension. JAMA 1997;13:1046\u20131051.","journal-title":"JAMA"},{"key":"211831_CR6","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1540-8159.1996.tb03367.x","volume":"19","author":"BP Grubb","year":"1996","unstructured":"Grubb BP, Kosinski D, Mouhaffel A, et al. The use of methylphenidate in the treatment of refractory neurocardiogenic syncope. PACE 1996;19:836\u2013840.","journal-title":"PACE"},{"key":"211831_CR7","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/clpt.1986.101","volume":"39","author":"PK Zachariah","year":"1986","unstructured":"Zachariah PK, Bloedow PC, Moyer TP, et al. Pharmacodynamics of midodrine, an antihypertensive agent. Clin Pharmacol Ther 1986;39:586\u2013589.","journal-title":"Clin Pharmacol Ther"},{"key":"211831_CR8","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1253\/jcj.56.950","volume":"56","author":"S Koyama","year":"1992","unstructured":"Koyama S, Matsubara T, Aizawa Y, et al. A case of vasovagal syncope with convulsions-The effects of midodrine hydrochloride. Jpn Circ J 1992;56:950\u2013954.","journal-title":"Jpn Circ J"},{"key":"211831_CR9","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF01818889","volume":"5","author":"C Ward","year":"1995","unstructured":"Ward C, Kenny RA. Observations on midodrine in a case of vasodepressor neurocardiogenic syncope. Clin Auton Res 1995;5:257\u2013260.","journal-title":"Clin Auton Res"},{"key":"211831_CR10","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1540-8167.1997.tb00607.x","volume":"8","author":"J Sra","year":"1997","unstructured":"Sra J, Maglio C, Biehl M, et al. Efficacy of midodrine hydrochloride in neurocardiogenic syncope refractory to standard therapy. J Cardiovasc Electrophysiol 1997;8:42\u201346.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"211831_CR11","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1540-8159.1997.tb03904.x","volume":"20","author":"BP Grubb","year":"1997","unstructured":"Grubb BP, Kosinski D. Tilt table testing: Concepts and limitations. PACE 1997;20(Part II):781\u2013787.","journal-title":"PACE"},{"key":"211831_CR12","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1001\/archinte.1991.00400120067011","volume":"151","author":"S Nelson","year":"1991","unstructured":"Nelson S, Stanley M, Love C, et al. Autonomic and hemodynamic effects of oral theophylline in patients with vasodepressor syncope. Arch Int Med 1991;151:2425\u20132429.","journal-title":"Arch Int Med"},{"key":"211831_CR13","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/0735-1097(93)90070-H","volume":"22","author":"M Strieper","year":"1993","unstructured":"Strieper M, Campbell R. Efficacy of alpha-adrenergic agonist therapy for the prevention of pediatric neurocardiogenic syncope. J Am Coll Cardiol 1993;22:594\u2013597.","journal-title":"J Am Coll Cardiol"},{"key":"211831_CR14","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/j.1540-8159.1993.tb01708.x","volume":"16","author":"A Susmano","year":"1993","unstructured":"Susmano A, Volgman A, Buckinham T. Beneficial effects of dextro-amphetamine in the treatment of vasodepressor syncope. PACE 1993;16:1235\u20131238.","journal-title":"PACE"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1009813312936.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1009813312936\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1009813312936.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T12:02:39Z","timestamp":1749211359000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1009813312936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,7]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1999,7]]}},"alternative-id":["211831"],"URL":"https:\/\/doi.org\/10.1023\/a:1009813312936","relation":{},"ISSN":["1383-875X","1572-8595"],"issn-type":[{"value":"1383-875X","type":"print"},{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,7]]}}}